FindTrial
Sign In

Safety and efficacy of "one-stop" combining atrial septal defect and left atrial appendage closure in patients with or without atrial fibrillation combined with atrial septal defect

Safety and efficacy of "one-stop" combining atrial septal defect and left atrial appendage closure in patients with or without atrial fibrillation combined with atrial septal defect

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085684
Enrollment
Unknown
Registered
2024-06-17
Start date
2024-06-20
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation, Atrial septal defect

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: (1) Preoperative transthoracic echocardiography or transesophageal echocardiography confirmed congenital secondary atrial septal defect; (2) Patients who completed one-stop interventional therapy (transcatheter atrial septal defect closure and left atrial ear closure at the same time); (3) Patients who have complete clinical data

Exclusion criteria

Exclusion criteria: (1) Patients with primary foramen ASD and venous sinus ASD; (2) Patients with other structural heart disease requiring surgical treatment

Design outcomes

Primary

MeasureTime frame
All-cause death;Heart failure;Severe bleeding;Occluder-associated thrombosis;Perioperative serious complications;Thromboembolism;Ischemic stroke;—

Countries

China

Contacts

Public ContactLi Huakang

The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University

lihuakang1980@163.com+86 139 8316 7113

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026